Thu, Aug 21, 2014, 10:35 AM EDT - U.S. Markets close in 5 hrs 25 mins


% | $
Quotes you view appear here for quick access.

Stereotaxis Inc. Message Board

  • panalta2000 panalta2000 Mar 2, 2013 6:25 PM Flag

    CEO comments in December could not have been any rosier:

    The company is seeing an acceleration in incoming orders which it believes will lead to "stronger financials in the future," said Stereotaxis' CEO Mike Kaminski. The response to Sterotaxis' new Vdrive, which enables surgeons to remotely manipulate catheters has been "exceptionally strong," the CEO said. The company estimates that 50% of its customers will upgrade to the new system this year and the product has triggered increased interest in buying new systems from Sterotaxis, Kaminski commented. Sterotaxis expects Vdrive to be launched in the U.S. in 2013, he added. Meanwhile, the company believes that it can expand to more geographic markets through additional partnerships, the CEO noted. In mid-morning trading, Stereotaxis jumped 70c, or 35%, to $2.70.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • and where is panalta today? lol

      Sentiment: Buy

    • We both obviously believe the stock has huge upside from current levels. I will let the numbers and outlook speak for itself.

    • I've seen a lot of grumbling about Kaminski's leadership as STXS CEO, mostly because of the product transition to Epoch. I do not blame him for what happened. Epoch was approved first in Europe, and when word of just how good it is was widely spread, US sales of the slower Niobe of course tanked. Expectations for this product line change could have been better managed, but no way the slow down while waiting for US Reg approval could have been avoided.

      Now, with Niobe ES (Epoch) fully available as both new systems and upgrades (wonder how much they beat the target of 50% of installed base upgraded in 2012?), things are going just fine, thank you! Layer onto that the upcoming reality of Vdrive sales in the US (already in Canada), and expanding international markets, and STXS should be coming into its rapid growth phase. PLUS, with Vdrive becoming more available, I fully expect clinicians to explore the other approved indications for Epoch.

      As ever, Strong Long, Strong Buy

      (hold onto your stock, fellow longs!)


      Sentiment: Strong Buy

2.900.00(0.00%)10:05 AMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.